Atherosclerosis
Volume 169, Issue 1 , Pages 131-138 , July 2003

Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function

  • William Bilsborough

      Affiliations

    • Department of Cardiothoracic Surgery, Royal Perth Hospital, GPO Box X2213, Perth 6847, WA, Australia
    • Department of Medicine, University of Western Australia, Perth, Australia
    • West Australian Institute for Medical Research, Perth, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-8-9224-3443; fax: +61-8-9224-1464
    • ,
  • Daniel J. Green

      Affiliations

    • Department of Human Movement and Exercise Science, University of Western Australia, Perth, Australia
    • Department of Cardiology, Royal Perth Hospital, Perth, Australia
    • West Australian Institute for Medical Research, Perth, Australia
    • ,
  • Cyril D.S. Mamotte

      Affiliations

    • Department of Immunology, Royal Perth Hospital, Perth, Australia
    • Department of Biochemistry, Royal Perth Hospital, Perth, Australia
    • West Australian Institute for Medical Research, Perth, Australia
    • ,
  • Frank M. van Bockxmeer

      Affiliations

    • Department of Biochemistry, Royal Perth Hospital, Perth, Australia
    • Department of Pathology, University of Western Australia, Perth, Australia
    • West Australian Institute for Medical Research, Perth, Australia
    • ,
  • Gerard J. O'Driscoll

      Affiliations

    • Department of Cardiology, Royal Perth Hospital, Perth, Australia
    • West Australian Institute for Medical Research, Perth, Australia
    • ,
  • Roger R. Taylor

      Affiliations

    • Department of Medicine, University of Western Australia, Perth, Australia
    • Department of Cardiology, Royal Perth Hospital, Perth, Australia
    • West Australian Institute for Medical Research, Perth, Australia

Received 4 December 2002 ,Revised 14 March 2003 ,Accepted 2 April 2003.

References 

  1. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319–1330
  2. Schroeder S, Enderele MD, Ossen R, et al.  Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrophysiology and myocardial perfusion imaging. Am. Heart J. 1999;138:731–739
  3. Halcox JPJ, Scenke WH, Gloria Z, et al.  Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–658
  4. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 1994;24:1468–1474
  5. Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Gen. Metab. 2000;70:241–251
  6. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 1996;2:41–45
  7. Wang XL, Mahaney MC, Sim AS, et al.  Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 1997;17:3147–3153
  8. Nakayama M, Yasue H, Yoshimura M, et al.  T(-786)→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am. J. Cardiol. 2000;86:628–634
  9. Kajiyama N, Saito Y, Miyamoto Y, et al.  Lack of association between T-786→C-mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens. Res. 2000;23:561–565
  10. Yoon Y, Song J, Hong SH, Kim JQ. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 2000;46:1626–1630
  11. Schneider MP, Erdmann J, Delles C, Fleck E, Regitz-Zagrosek V, Schmieder RE. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J. Hypertens. 2000;18:1767–1773
  12. Komatsu M, Kawagishi T, Emoto M, et al.  ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2002;283:H557–H561
  13. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314–1319
  14. Granath B, Taylor RR, van Bockxmeer FM, Mamotte CDS. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J. Cardiovasc. Risk. 2001;8:235–241
  15. Woodman R, Playford D, Watts G, et al.  Improved analysis of brachial artery ultrasound images using a novel edge-detection software system. J. Appl. Physiol. 2001;91:929–937
  16. Tsukada T, Yokoyama K, Arai T, et al.  Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 1998;245:190–193
  17. Wang XL, Sim AS, Wang MX, Murrell GA, Trudinger B, Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000;471:45–50
  18. Nakayama M, Yasue H, Yoshimura M, et al.  T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864–2870
  19. Poirier O, Mao C, Mallet C, et al.  Polymorphisms of the endothelial nitric oxide synthase gene no consistent association with myocardial infarction in the ECTIM study. Eur. J. Clin. Invest. 1999;29:284–290
  20. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 1996;98:5–7
  21. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Invest. 1996;98:24–29
  22. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J. Am. Coll. Cardiol. 1999;34:2002–2006
  23. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95:1119–1121
  24. Chambers JC, Ueland PM, Wright M, Dore CJ, Refsum H, Kooner JS. Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects. Circ. Res. 2001;89:187–192
  25. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Newcombe RG, Lewis MJ. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur. J. Clin. Invest. 1999;29:659–662
  26. Verhaar MC, Wever RM, Kastelein JJ, van Loon D, Milstien S, Koomans HA, et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation. 1999;100:335–338
  27. Doshi SN, McDowell IF, Moat SJ, et al.  Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide. Arterioscler. Thromb. Vasc. Biol. 2001;21:1196–1202
  28. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000;102:2479–2483
  29. Homocysteine Lowering Trialists’ Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br. Med. J. 1998;316:894–898
  30. Loscalzo J. Folate and nitrate-induced endothelial dysfunction: a simple treatment for a complex pathobiology. Circulation. 2001;104:1086–1088
  31. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am. J. Cardiol. 1991;68:1425–1430
  32. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 1990;86:228–234
  33. Landmesser U, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin. Thromb. Hemost. 2000;26:529–537
  34. Toikka JO, Ahotupa M, Viikari JS, et al.  Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis. 1999;147:133–138
  35. Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int. J. Cardiol. 2000;73:231–236
  36. Spieker LE, Sudano I, Hurlimann D, et al.  High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation. 2002;105:1399–1402

PII: S0021-9150(03)00147-3

doi: 10.1016/S0021-9150(03)00147-3

Atherosclerosis
Volume 169, Issue 1 , Pages 131-138 , July 2003

Article Tools

* Image Usage & Resolution